DESLORATADINE TARBIS 0.5 mg/ml ORAL SOLUTION
How to use DESLORATADINE TARBIS 0.5 mg/ml ORAL SOLUTION
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the Patient
Desloratadine Tarbis0.5 mg/ml Oral Solution EFG
Read this entire leaflet carefully before starting to take this medicine, as it contains important information for you.
- Keep this leaflet, as you may need to read it again. If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
- If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.
Contents of the Package Leaflet
- What is Desloratadine Tarbis and what is it used for
- What you need to know before taking Desloratadine Tarbis
- How to take Desloratadine Tarbis
- Possible side effects
- Storage of Desloratadine Tarbis
- Package Contents and Additional Information
1. What is Desloratadine Tarbis and what is it used for
Desloratadine Tarbis oral solution is a non-drowsy antiallergic medicine that helps control allergic reactions and their symptoms.
Desloratadine Tarbis oral solution relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, such as hay fever or dust mite allergy). These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red, or watery eyes.
Desloratadine Tarbis oral solution is also used to relieve symptoms associated with urticaria (a skin disease caused by an allergy). These symptoms include itching and skin hives.
Relief from these symptoms lasts a full day and helps you continue your daily activities and normal sleep periods.
Desloratadine Tarbis oral solution is indicated for children from 1 to 11 years of age, adolescents (from 12 years of age), and adults, including the elderly.
2. What you need to know before taking Desloratadine Tarbis
Do not takeDesloratadine Tarbis
- if you are allergic (hypersensitive) to desloratadine, loratadine, or any of the other ingredients of Desloratadine Tarbis (listed in section 6)
Warnings and Precautions
- if you have impaired kidney function.
- if you have a personal or family history of seizures
If this happens to you, or if you are unsure, consult your doctor before taking Desloratadine Tarbis.
TakingDesloratadine Tarbiswith other medicines
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
There are no known interactions between Desloratadine Tarbis and other medicines.
TakingDesloratadine Tarbiswith food and drinks
Desloratadine Tarbis can be taken with or without food.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and Using Machines
The influence of desloratadine on the ability to drive and use machines is negligible. At the recommended dose, Desloratadine Tarbis is not expected to cause drowsiness or affect your attention. However, very rarely, some people may experience drowsiness, which may affect their ability to drive or use machines.
Desloratadine Tarbiscontains sorbitol
Desloratadine Tarbis contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
3. How to take Desloratadine Tarbis
Follow the instructions for administration of this medicine indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Children from 1 to 5 years of age: take 2.5 ml of oral solution once a day.
Children from 6 to 11 years of age: take 5 ml of oral solution once a day.
Adults and adolescents: take 10 ml (two 5 ml spoonfuls) of oral solution once a day.
Swallow the dose of oral solution, and then drink a little water. You can take this medicine with or without food.
Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you have and how long you should take Desloratadine Tarbis oral solution.
If your allergic rhinitis is intermittent (symptoms present for less than 4 days a week or for less than 4 weeks), your doctor will recommend a treatment schedule based on the evaluation of your medical history.
If your allergic rhinitis is persistent (symptoms present for 4 or more days a week and for more than 4 weeks), your doctor may recommend long-term treatment.
For urticaria, the duration of treatment may vary from patient to patient, and you should follow your doctor's instructions.
If you take moreDesloratadine Tarbisthan you should
Take Desloratadine Tarbis only as your doctor has indicated. An accidental overdose is not expected to cause serious problems.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takeDesloratadine Tarbis
If you forget to take your dose at the scheduled time, take it as soon as possible, and then continue with your regular dosing schedule. Do not take a double dose to make up for missed doses.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Desloratadine Tarbis can cause side effects, although not everyone gets them.
In adults, side effects were approximately the same as with a placebo. However, fatigue, dry mouth, and headache were reported more frequently than with a placebo. In adolescents, headache was the most commonly reported adverse reaction.
During the marketing of Desloratadine Tarbis, very rare cases of severe allergic reactions (difficulty breathing, wheezing, itching, skin hives, and swelling) and skin rash have been reported. Palpitations, rapid heartbeats, stomach pain, nausea (vomiting), vomiting, upset stomach, diarrhea, dizziness, drowsiness, difficulty sleeping, muscle pain, hallucinations, seizures, agitation with increased body movement, liver inflammation, and changes in liver function tests have also been reported very rarely.
The following side effects have been reported, but their frequency cannot be estimated from the available data (Frequency not known): abnormal behavior, aggression, changes in heart rhythm, depressed mood, dry eyes, weight gain, and increased appetite.
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.
5. Storage of Desloratadine Tarbis
Keep out of sight and reach of children.
Do not freeze.
No special storage conditions are required
The solution is stable for 48 days after first opening. Do not store above 25°C.
Do not use this medicine after the expiration date stated on the carton and bottle after EXP. The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
6. Package Contents and Additional Information
Composition of Desloratadine Tarbis
- The active ingredient is desloratadine 0.5 mg/ml
- The other ingredients of the oral solution are sodium benzoate, sodium saccharin, sorbitol, propylene glycol, anhydrous citric acid, hydroxyethylcellulose, orange flavor, and purified water.
Appearance of the Product and Package Contents
The oral solution is transparent, practically colorless, and has an orange flavor.
Desloratadine Tarbis oral solution is available in a 60 ml, 100 ml, 120 ml, and 150 ml amber polyethylene terephthalate (PET) bottle with a child-resistant screw cap and a dosing cup with marks for 2.5 ml, 5 ml, and 10 ml doses.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Tarbis Farma, S.L.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer:
Laboratorios NORMON, S.A.
Ronda de Valdecarrizo, 6
ES – 28760 Tres Cantos, Madrid
Spain
You can request more information about this medicine from the local representative of the Marketing Authorization Holder
Date of the last revision of this leaflet: December 2022
“Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es/”
- Country of registration
- Average pharmacy price3.98 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to DESLORATADINE TARBIS 0.5 mg/ml ORAL SOLUTIONDosage form: ORAL SOLUTION/SUSPENSION, 0.5 mgActive substance: desloratadineManufacturer: Organon N.V.Prescription requiredDosage form: ORALLY DISINTEGRATING TABLET/LIOTAB, 5 mgActive substance: desloratadineManufacturer: Organon N.V.Prescription requiredDosage form: TABLET, 5 mgActive substance: desloratadineManufacturer: Organon N.V.Prescription required
Online doctors for DESLORATADINE TARBIS 0.5 mg/ml ORAL SOLUTION
Discuss questions about DESLORATADINE TARBIS 0.5 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
